HealthDay - WEDNESDAY, Feb. 29 (HealthDay News) -- Seniors may not benefit from prostate cancer treatment, according to a new study that found aggressive therapy has become more common among men with short life expectancies and less aggressive forms of the disease.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.